Amundi Sells 508,928 Shares of Acadia Healthcare Company, Inc. $ACHC

Key Points

• Amundi cut its Acadia Healthcare position by 96.9% in the second quarter, selling 508,928 shares and retaining 16,156 shares valued at approximately $477,000.
• Acadia reported quarterly EPS of $0.38, above the $0.35 consensus estimate, while revenue of $865.84 million also exceeded expectations; however, revenue declined 0.4% year over year and the company posted a negative net margin.
• Analyst sentiment is mixed, with an overall “Hold” rating and a consensus price target of $29.85. Shares recently opened at $28.16, compared with a 52-week range of $11.43 to $35.83.

Amundi decreased its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 96.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 16,156 shares of the company's stock after selling 508,928 shares during the quarter. Amundi's holdings in Acadia Healthcare were worth $477,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Allworth Financial LP purchased a new position in Acadia Healthcare during the 2nd quarter valued at about $45,000. Global Retirement Partners LLC purchased a new stake in shares of Acadia Healthcare in the 2nd quarter worth approximately $68,000. Quantbot Technologies LP bought a new position in shares of Acadia Healthcare during the second quarter valued at approximately $88,000. Teachers Retirement System of The State of Kentucky increased its holdings in Acadia Healthcare by 5.1% during the first quarter. Teachers Retirement System of The State of Kentucky now owns 75,095 shares of the company's stock valued at $1,757,000 after buying an additional 3,642 shares during the period. Finally, PNC Financial Services Group Inc. increased its holdings in Acadia Healthcare by 103.5% during the first quarter. PNC Financial Services Group Inc. now owns 7,234 shares of the company's stock valued at $169,000 after buying an additional 3,680 shares during the period.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $28.16 on Thursday. The business has a fifty day moving average of $30.26 and a 200 day moving average of $27.14. Acadia Healthcare Company, Inc. has a 1 year low of $11.43 and a 1 year high of $35.83. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.57 and a quick ratio of 1.57. The firm has a market capitalization of $2.62 billion, a price-to-earnings ratio of -2.26, a price-to-earnings-growth ratio of 8.82 and a beta of 0.62.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.03. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The business had revenue of $865.84 million for the quarter, compared to the consensus estimate of $844.19 million. During the same quarter in the previous year, the business earned $0.83 EPS. The company's quarterly revenue was down .4% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, research analysts expect that Acadia Healthcare Company, Inc. will post 1.55 earnings per share for the current year.

Wall Street Analyst Weigh In

ACHC has been the subject of a number of analyst reports. UBS Group upped their price objective on Acadia Healthcare from $31.00 to $39.00 and gave the stock a "buy" rating in a research note on Thursday, July 9th. Barclays boosted their target price on shares of Acadia Healthcare from $25.00 to $32.00 and gave the stock an "equal weight" rating in a report on Thursday, July 30th. Weiss Ratings restated a "sell (d)" rating on shares of Acadia Healthcare in a report on Wednesday, September 9th. TD Cowen lifted their price objective on shares of Acadia Healthcare from $30.00 to $36.00 and gave the stock a "buy" rating in a research report on Tuesday, July 14th. Finally, KeyCorp increased their target price on shares of Acadia Healthcare from $30.00 to $40.00 and gave the company an "overweight" rating in a research report on Tuesday, July 14th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, Acadia Healthcare currently has an average rating of "Hold" and a consensus target price of $29.85.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The company operates facilities that offer treatment for mental health conditions, substance use disorders and other behavioral health needs. Its services are designed for children, adolescents and adults and may include inpatient psychiatric care, residential treatment, outpatient programs and specialized care.

Acadia's facilities provide a range of treatment programs, including psychiatric hospitals, addiction treatment centers, eating disorder programs and other specialty behavioral healthcare services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.